InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Morningside Venture Investments Ltd. Officer active across 3 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 8 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €17.7m. Activity tracked since 18 November 2021. The latest transaction was filed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
12,857,931 sharesCommon StockSEC:0000899243-22-011429:0
10,415,650 sharesCommon StockSEC:0000899243-22-011432:0
12,858,188 sharesCommon StockSEC:0000899243-22-004855
12,858,188 sharesCommon StockSEC:0000899243-22-004855:0
10,415,650 sharesCommon StockSEC:0000899243-22-003157
10,415,650 sharesCommon StockSEC:0000899243-22-003157:0
250,000 shares@ US$40.000.17% mcap50.0% of flowCommon StockSEC:0000899243-21-045265:0
Ideal exit: 15 Aug 2022 (T+270)
250,000 shares@ US$40.000.17% mcap100.0% of flowCommon StockSEC:0000899243-21-045265
Ideal exit: 15 Aug 2022 (T+270)
8 of 8 declarations
About Morningside Venture Investments Ltd
Morningside Venture Investments Ltd is a director and insider at Apellis Pharmaceuticals, Inc., Amylyx Pharmaceuticals, Inc., and GreenLight Biosciences Holdings, PBC.
